Skip to content
  • 6,816 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Vendor, Tarrytown, NY

Regeneron Pharmaceuticals Inc.

UEI N3F9MH7E6HD6, CAGE 544P9

6 awards and -$53,744,108 obligated between January 2, 2024 and September 25, 2026, 83% under full and open competition, against 167.5 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.

Sells to

Awarding agencies by dollars.

Department of Veterans Affairs$0
Office of Assistant Secretary for Preparedness and Response-$53,744,108

Industries

NAICS on the awards, by dollars.

Pharmaceutical Preparation ManufacturingNAICS 325412$0
Professional, Scientific, and Technical ServicesNAICS 541711-$53,744,108

How it wins

Awards by competition, set-aside and type.

Full and Open Competition5
Not Competed1
Definitive Contract3

Hear when Regeneron Pharmaceuticals Inc. wins an award and when a contract it holds is about to end.Follow it

Contracts ending soon

Contracts Regeneron Pharmaceuticals Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.

Ending
1
Obligated so far
-$332,474,556
Soonest
September 25, 2027

The 1 contract, the office behind each one and the dates are in the workspace. See them

Competes with

Vendors selling pharmaceutical preparation manufacturing to Department of Veterans Affairs, by dollars.

Mckesson CorporationIrving, TX$31,461,755,412
Exelan Pharmaceuticals Inc.Boca Raton, FL$175,193,835
Progenics Pharmaceuticals Inc.North Billerica, MA$98,046,501
Cardinal Health 414, LLCDublin, OH$75,939,729
Novartis Pharmaceuticals CorporationEast Hanover, NJ$56,726,790
Sofie Co.Dulles, VA$25,337,798

Solicitations it won

SAM.gov opportunities whose award USAspending attributes to this vendor.

Awards

Every award in the window, by dollars obligated.

ContractObligated
HHSO100201700016CDefinitive Contract, December 6, 2024, Full and Open Competition, 2 offersSolicitation $280,503,480
36E79721A0023August 29, 2024, Full and Open Competition, 1 offers$0
36F79721D0169January 2, 2024, Full and Open Competition, 999 offers$0
HHSO100201600023CDefinitive Contract, March 19, 2026, Not Competed, 1 offers-$337,504
HHSO100201500013CJuly 23, 2024, Full and Open Competition, 1 offers-$1,435,528
HHSO100201700020CDefinitive Contract, December 5, 2024, Full and Open Competition, 1 offers-$332,474,556
Places of performance
New York
Transactions
43 across 6 awards